Diagnostic

Molbio Diagnostics IPO: Molbio is a molecular diagnostic company that develops, manufactures, and commercializes point-of-care (POC) molecular diagnostic platforms.

Updated On: 10 Aug 2026 | 9:11 AM IST

Sector to outshine healthcare peers as higher volumes, steady realisations will boost revenue and profit, say analysts

Updated On: 12 Apr 2026 | 10:07 PM IST

Do vaccines cause autism? Is it bad parenting? Can autism be cured? In this episode of our fact-check series, experts debunk common autism myths and explain how misinformation delays diagnosis and fue

Updated On: 02 Jan 2026 | 11:06 AM IST
Icon Youtube

Fitness firm Fittr is moving towards providing a holistic preventive healthcare service, combining diagnostics with doctor consultations, to target non-communicable diseases, according to its founder and CEO Jitendra Chouksey. The firm has earmarked investment of up to Rs 15 crore to set up company-owned diagnostic laboratories in five metro cities, while also collaborating with partners to expand its lab network to 5,000 pin codes across India, Chouksey told PTI. "We are moving towards a preventive healthcare ecosystem, where we are combining diagnostics with doctor consultations, along with coaching and wearable monitoring, to address one of the biggest pain points in the country today, which is the growing number of NCD (non-communicable diseases) deaths, which are happening in the country," he said. Earlier, Fittr operated primarily as a fitness company, where it used to render nutrition and training services with the help of its coaches, he noted. Chouksey was responding to a

Updated On: 28 Dec 2025 | 10:48 AM IST

India's diagnostics sector is seeing a strong shift towards preventive and precision-led testing in 2025, driven by rising demand for proactive health checks and faster genomic diagnostics

Updated On: 24 Dec 2025 | 6:13 PM IST

Chennai-based Aarthi Scans plans to add 65 new centres by 2030, with 90% in North India, while exploring fitness diagnostics and targeting a Rs 600 crore turnover

Updated On: 21 Jul 2025 | 4:13 PM IST

Suraksha Diagnostics on Wednesday said it will invest Rs 200 crore to set up over 20 advanced imaging centres across eastern India. The plan, which will be executed in collaboration with United Imaging, is aimed at expanding access to advanced diagnostic services in tier 2 and tier 3 cities, enhancing both affordability and healthcare quality in smaller towns and semi-urban regions, it said. No timeline was, however, revealed for the investment rollout. "This collaboration will assist us in expanding our reach and offer high-quality diagnostic services to a large population in eastern India," Suraksha Diagnostics CMD Somnath Chatterjee said. United Imaging will supply cutting-edge imaging solutions, while Suraksha Diagnostics will leverage its existing network and operational expertise to set up the new centres, the company said. Suraksha Diagnostics raised Rs 846.25 crore through an IPO in December for funding its expansion plans. At present, it operates 59 diagnostic centres an

Updated On: 18 Jun 2025 | 1:50 PM IST

With its third acquisition in recent times, Metropolis' Ameera Shah said the firm will make another deal this financial year

Updated On: 07 Apr 2025 | 10:54 PM IST

Realisation growth for Dr Lal PathLabs and Vijaya Diagnostic Centre is projected to remain flat compared to the previous year

Updated On: 12 Jan 2025 | 10:15 PM IST

The competition watchdog CCI on Tuesday approved Fortis Healthcare's proposal to acquire an additional 31.52 per cent stake in Agilus Diagnostics. Multi-speciality hospital chain Fortis Healthcare Ltd (FHL) is engaged in providing integrated healthcare delivery services like medicare, healthcare and diagnostics. The diagnostics services business of FHL is being undertaken primarily through Agilus. "Commission approves the acquisition of additional 31.52 per cent share capital of Agilus Diagnostics Ltd by Fortis Healthcare Ltd," according to a post by CCI on X. After the transaction, the shareholding of Fortis Healthcare Ltd (FHL) in Agilus will increase from 57.68 per cent to 89.2 per cent. In August, Fortis Healthcare announced that it will acquire a 31 per cent stake in Agilus Diagnostics for Rs 1,780 crore valuing Agilus at Rs 5,700 crore. The Competition Commission of India (CCI) has also cleared the proposed merger of Diliigent Power into DB Power, and the reorganisation of

Updated On: 29 Oct 2024 | 8:52 PM IST

Easing of pressure from predatory pricing and steady network expansion is boosting growth for diagnostics companies, say Abdulkader Puranwala and Nisha Shetty of ICICI Securities

Updated On: 27 Aug 2024 | 11:17 PM IST

The projected rise in revenue comes on the back of an estimated 8% growth in FY24

Updated On: 10 Apr 2024 | 7:15 PM IST

The participation aims to add to the diagnostic service provider's international portfolio. Its international network consists of several centres and pick-up points (PUPs) across multiple locations

Updated On: 07 Mar 2024 | 6:23 PM IST

Covid-19 led to increase in self-testing awareness, particularly about preventive and wellness services

Updated On: 24 Feb 2024 | 8:51 AM IST

It may be possible to detect signs of Parkinson's disease 20-30 years before symptoms appear, according to researchers in Australia. A biomarker called F-AV-133, used in combination with PET, or positron emission tomography, scans can help diagnose Parkinson's disease and accurately track neurodegeneration, the researchers from the Florey Institute of Neuroscience and Mental Health, Melbourne, said. F-AV-133 is an imaging agent and has shown promise as a PET tracer for detecting and monitoring neurodegeneration in Parkinson's disease, a progressive neurological disorder characterised by tremor and impaired muscular coordination. According to the researchers, the disease, often thought of as an illness of old age, in fact, starts in midlife and can go undetected for decades. "Parkinson's disease is very hard to diagnose until symptoms are obvious, by which time up to 85 per cent of the brain's neurons that control motor coordination have been destroyed. At that point, many treatment

Updated On: 12 Oct 2023 | 2:30 PM IST

Dilip filed a complaint before the Delhi State Commission, alleging that the RFA procedure was carried out without his knowledge or consent, and also without considering the findings of the EPS

Updated On: 19 Feb 2023 | 9:33 PM IST

Med-tech companies are working round the clock to come up with AI-based solutions

Updated On: 14 Feb 2023 | 8:17 PM IST

Cippoint offers parameters to test for cardiac markers, diabetes, infectious diseases, fertility

Updated On: 18 Jan 2023 | 11:55 AM IST

"We are now getting to 'wet' pathology tests like blood tests etc and we have set up a centre which will have minimal human intervention and maximum automation

Updated On: 28 Jul 2022 | 11:42 PM IST

A company called Torrent Diagnostics Private Ltd was incorporated in February this year and has a Torrent Pharmaceuticals executive director as one of its directors

Updated On: 21 Jul 2022 | 1:30 AM IST